The insurance industry cycles between competitive "soft" markets and profitable "hard" markets. Kinsale's model is built to accept slower growth rather than chase unprofitable business in soft periods. This preserves capital and positions them to aggressively gain market share when discipline returns to the industry.

Bond insurer Assured Guaranty isn't in a high-growth industry, but its management consistently buys back 12-13% of its shares annually at a large discount to book value. This superior capital allocation has driven extraordinary growth in book value per share.

The company's Total Return Swaps (TRS) are not just a speculative bet but a strategic tool. They function as a deferred buyback, allowing Fairfax to lock in a price while using the capital elsewhere until they formally close the swap and take delivery of the shares.

Companies termed "share cannibals" aggressively repurchase their own shares, especially when undervalued. This capital allocation strategy is often superior to dividends because it transfers value from sellers to long-term shareholders and acts as a high-return, low-risk investment in the company's own business.

Fairfax follows a clear capital allocation framework. They prioritize open market buybacks when the stock is below 1.5 times price-to-book. Above that multiple, they shift capital towards closing out their Total Return Swaps, providing a predictable approach for investors.

The book "The Fairfax Way" reveals the company's early success wasn't merely from acquiring insurers at low valuations. The critical, often overlooked element was the immense time, money, and work required to revamp and stabilize these acquired operations to an acceptable level, a key lesson for value investors.

Fairfax executed a brilliant capital allocation move by selling a 10% stake in its subsidiary, Odyssey, to pension funds for 1.7 times its book value. They then used the billion-dollar proceeds to buy back their own undervalued parent company stock, which was trading at a discount of 0.9x book value.

Fairfax maintains a balance sheet with roughly $75 billion in investments against $25 billion in equity. This leverage is primarily funded by low-cost insurance float and some debt, creating a powerful engine for returns that the speakers argue is a "better mousetrap than Berkshire."

Instead of complaining that its stock trades at a steep discount to its net asset value (NAV), Exor's management pragmatically views this as a chance to invest in themselves. They trimmed their highly appreciated Ferrari stake specifically to fund share buybacks at this significant discount.